GENN

Genesis Healthcare, Inc. [GENN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

GENN Stock Summary

In the News

04:01 28 Mar 2024 GENN

Genesis HealthCare Announces Universal COVID-19 Vaccination for Employees, Care Partners and Onsite Vendors

KENNETT SQUARE, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Genesis HealthCare, (“Genesis” or “Company”) (OTC PINK: GENN), a national post-acute care provider, announced today that it is adopting a universal COVID-19 vaccination requirement for employees, care partners, and onsite vendors across the Company.

GENN Financial details

Company Rating
Sell
Market Cap
11.17K
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
0.13
Dividend %
11.82K%
Employees
44K
Optionable
No
Shortable
Yes
Earnings
19 Mar 2024
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
0.18
Current Ratio
0.23
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
1%
ROA
-3%
ROE
11%
ROC
0.2%
Gross Margin
42%
Oper. Margin
1%
Profit Margin
-3%
Payout
-
Shs Outstand
111.73M
Shs Float
107.73M
-
-
-
-
Target Price
-
52W Range
1.0E-4-0.37555
52W High
-
52W Low
-
RSI
33.49
Rel Volume
0.01
Avg Volume
31.82K
Volume
400
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
-35.29%
-
-
-
-
Beta
-0.49
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0011
Change
0%

GENN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
49.2727.6234.9200
Net income per share
-2.330.05-0.9200
Operating cash flow per share
0.18-0.042.8200
Free cash flow per share
-0.32-0.422.3300
Cash per share
0.560.272.2500
Book value per share
-20.24-6.55-7.3300
Tangible book value per share
-22.27-7.6-11.8900
Share holders equity per share
-20.24-6.55-7.3300
Interest debt per share
53.2128.1835.2800
Market cap
119.19M271.11M54.21M00
Enterprise value
4.88B4.43B3.65B00
P/E ratio
-0.5136.27-0.5200
Price to sales ratio
0.020.060.0100
POCF ratio
6.41-37.830.1700
PFCF ratio
-3.66-3.880.2100
P/B Ratio
-0.06-0.25-0.0700
PTB ratio
-0.06-0.25-0.0700
EV to sales
0.980.970.9300
Enterprise value over EBITDA
1112.7123.9800
EV to operating cash flow
262.71-618.311.5700
EV to free cash flow
-149.91-63.3914.0400
Earnings yield
-1.970.03-1.9100
Free cash flow yield
-0.27-0.264.800
Debt to equity
-2.4-4.14-4.6500
Debt to assets
1.150.960.9400
Net debt to EBITDA
10.7311.9323.6300
Current ratio
0.960.770.2300
Interest coverage
0.451.250.3300
Income quality
-0.05-0.96-3.0500
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.060.120.1400
Research and developement to revenue
00000
Intangibles to total assets
0.050.040.0400
Capex to operating cash flow
-2.758.75-0.1800
Capex to revenue
-0.01-0.01-0.0100
Capex to depreciation
-0.23-0.51-0.5200
Stock based compensation to revenue
00000
Graham number
32.572.5812.3500
ROIC
0.030.030.0100
Return on tangible assets
-0.060-0.0300
Graham Net
-56.91-31.72-40.7800
Working capital
-36.59M-242.32M-2.98B00
Tangible asset value
-2.25B-1.26B-1.33B00
Net current asset value
-5.43B-4.92B-4.36B00
Invested capital
-2.4-4.14-4.6500
Average receivables
673.43M595.18M497.28M213.46M0
Average payables
260.21M236.59M224.87M105.68M0
Average inventory
36.88M68.43M123.05M91.5M0
Days sales outstanding
45.6745.3839.8900
Days payables outstanding
30.7535.0134.1900
Days of inventory on hand
9.669.2729.6100
Receivables turnover
7.998.049.1500
Payables turnover
11.8710.4210.6700
Inventory turnover
37.7839.3812.3300
ROE
0.12-0.010.1300
Capex per share
-0.51-0.38-0.500

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
00000
Enterprise value
00000
P/E ratio
00000
Price to sales ratio
00000
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
00000
PTB ratio
00000
EV to sales
00000
Enterprise value over EBITDA
00000
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
00000
Current ratio
00000
Interest coverage
00000
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
00000
ROIC
00000
Return on tangible assets
00000
Graham Net
00000
Working capital
00000
Tangible asset value
00000
Net current asset value
00000
Invested capital
00000
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
00000
Capex per share
00000

GENN Frequently Asked Questions

What is Genesis Healthcare, Inc. stock symbol ?

Genesis Healthcare, Inc. is a US stock , located in Kennett square of Pa and trading under the symbol GENN

What is Genesis Healthcare, Inc. stock quote today ?

Genesis Healthcare, Inc. stock price is $0.0011 today.

Is Genesis Healthcare, Inc. stock public?

Yes, Genesis Healthcare, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Price Range
Similar Market Cap